Synchronous inter-piconet routing

Details for Australian Patent Application No. 2005234376 (hide)

International Classifications

Event Publications

12 October 2006 PCT application entered the National Phase

PCT publication WO2005/101768 Priority application(s): WO2005/101768

22 January 2009 Application Accepted

Published as AU-B-2005234376

26 February 2009 Application for Amendment

The nature of the amendment is as shown in the state- ment(s) filed 10 Feb 2009. Address for service in Australia - Madderns Level 1 64 Hindmarsh Sq Adelaide SA 5000 2005238390 42- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2one derivatives as p38 MAPkinase inhibitors for the treatment of inflammatory diseases Mitsubishi Tanabe Pharma Corporation The nature of the amendment is as shown in the statement(s) filed 05 Feb 2009. Address for service in Australia - Phillips Ormonde Fitzpatrick Lev

25 June 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 10 Feb 2009

2 July 2009 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.